Return to Care - Clinical Series: Ventilation/Perfusion (V/Q) Lung Studies
Organized by the SNMMI COVID-19 Task Force
Munir Ghesani, MD
Diagnostic Radiology Attending
Chief of Nuclear Medicine and Molecular Imaging
Mount Sinai Health System
New York, NY
The SNMMI is excited to launch a new webinar series – “Return to Care – Clinical Series.” As a professional society representing more than 16,000 nuclear medicine professionals, it is our responsibility to ensure the health and safety of our patients and members by distributing recommendations to mitigate the risk of COVID-19 transmission in clinical practice. This new series will focus on considerations for Nuclear Medicine and Molecular Imaging. The first webinar in the “Return to Care - Clinical Series” will focus on Ventilation/Perfusion (V/Q) Lung Studies. This topic was selected in response to the revised statement issued in March 2021 and the need to continue to provide the most up-to-date information to our members.
Annmarie Alessi, BS, NMTCB(CNMT), (RS), RT(N), FSNMMI-TS
Senior Manager, Product Sales, Nuclear Medicine, Radiation Safety Officer, Biodex Medical Systems, Inc. (Now Part of Mirion Technologies)
Fred Gattas, Pharm.D., BCNP, FAPhA
Director on Medical and Safety Affairs for North America, Curium
Norman LaFrance, MD
Chief Medical Officer, Senior Vice President, Jubilant Pharma Limited
Chief Executive Officer (CEO), Medi Nuclear Corporation, Inc.
There will be no CE offered for this webinar.